Preprint
Article

This version is not peer-reviewed.

Bromelain: Unveiling Its Potential as a Natural Anti-inflammatory Agent through Effective Binding to Apoptosis-Associated Speck-Like Containing CARD (ASC)

Submitted:

01 September 2024

Posted:

03 September 2024

You are already at the latest version

Abstract
This theoretical study presents a novel perspective on the potential anti-inflammatory properties of Bromelain, a natural agent extracted from pineapple stems. The investigation explores the binding capabilities of Bromelain to Apoptosis-associated speck-like containing CARD (ASC), a crucial adapter molecule known for its involvement in inflammatory processes and inflammasome formation. For the first time, these findings suggest that Bromelain exhibits a notable affinity for ASC, indicating its promising role as a natural anti-inflammatory agent. This study sheds light on the molecular interactions that may contribute to Bromelain's therapeutic potential in modulating inflammatory responses.
Keywords: 
;  ;  

1. Introduction

The Apoptosis-associated speck-like containing CARD (ASC), also known as PYCARD, is a crucial adapter molecule in inflammatory processes. Its primary role involves the formation of inflammasomes, multiprotein complexes that activate caspases, leading to inflammation and programmed cell death. ASC comprises PYD and CARD domains, facilitating interactions with similar domains in other proteins for inflammasome assembly [1,2,3]. While inflammasome activation is vital for the immune response against infections and cell damage, excessive activation can contribute to chronic inflammatory, autoimmune, or metabolic diseases. Consequently, understanding and regulating ASC and inflammasome activity are significant areas of research for potential therapeutic interventions in inflammation-related disorders [4,5]. The aim of this concise investigation is to examine the interplay between Apoptosis-associated speck-like containing CARD (ASC) and Bromelain through computational methods.Bromelain, known for its capacity to modulate inflammatory states, is composed of enzymes with proteolytic activity primarily extracted from pineapple stems [6,7,8].
The computational method employed to scrutinize potential binding and interactions between ASC and Bromelain at a molecular level was the HDOCK Server.
Broadly speaking, this is a protein-protein or protein-DNA/RNA docking approach based on a hybrid algorithm, incorporating template-based modeling and ab initio free docking [9,10].
Comprehending these interactions may offer insights into how Bromelain could impact ASC-mediated processes, such as inflammasome assembly and inflammation. Given Bromelain's recognized anti-inflammatory properties, investigating its influence on ASC through computational approaches may enhance our understanding of its therapeutic potential in modulating inflammatory responses.

2. Material and Methods

The HDOCK server was employed to predict the binding complexes between two molecules, specifically proteins represented by PDB Code 6U7D (Bromelain precursor used as the receptor) and PDB Code 2KN6 (Apoptosis-associated speck-like protein containing a CARD in CHAIN A used as the ligand). This prediction was carried out using a hybrid docking strategy.

3. Results and Discussion

The objective of this brief study is to explore the interaction between Apoptosis-associated speck-like containing CARD (ASC) and Bromelain using computational methods. Bromelain, recognized for its ability to regulate inflammatory states, is a group of enzymes with proteolytic activity primarily extracted from pineapple stems [6,7,8].
The computational method employed for the analysis of potential binding and interactions between ASC and Bromelain at a molecular level was the HDOCK Server [9,10]. The primary findings are presented in Figure 1, illustrating the outcomes of the interaction study. Table 1 provides the docking results by the HDOCK Server, demonstrating an excellent docking score and potential affinity between Bromelain and Apoptosis-associated speck-like containing CARD. Additionally, Table 2, Table 3 and Table 4 outlines the residues at the interface between the two targets.

4. Conclusions

This theoretical study presents a novel perspective on the potential anti-inflammatory properties of Bromelain, a natural agent extracted from pineapple stems. The investigation delves into Bromelain's binding capabilities with Apoptosis-associated speck-like containing CARD (ASC), a pivotal adapter molecule implicated in inflammatory processes and inflammasome formation. This study unveils molecular interactions that may underpin Bromelain's therapeutic potential in modulating inflammatory responses.

References

  1. Koizumi, M.; Watanabe, T.; Masumoto, J.; Sunago, K.; Imamura, Y.; Kanemitsu, K.; Hiasa, Y. (2021). Apoptosis-associated speck-like protein containing a CARD regulates the growth of pancreatic ductal adenocarcinoma. Scientific Reports, 11, 22351. [CrossRef]
  2. Tang, X.; Liu, X.; Wang, Z.; Chen, M.; Zhang, D. (2023). Molecular Characterization, Expression, and Regulatory Signal Pathway Analysis of Inflammasome Component Apoptosis-Associated Speck-like Protein Containing a CARD Domain (ASC) in Large Yellow Croaker (Larimichthys crocea). International Journal of Molecular Sciences, 24, 2175. [CrossRef]
  3. de Alba, E. (2009). Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC). Journal of Biological Chemistry, 284, 32932–32941. [CrossRef]
  4. Petrilli, V.; Papin, S.; Tschopp, J. (2005). The inflammasome. Current Biology, 15, R581.
  5. Man, S.M.; Kanneganti, T.D. (2015). Regulation of inflammasome activation. Immunological reviews, 265, 6–21. [CrossRef]
  6. Seligman, B. (1962). Bromelain: An anti-inflammatory agent. Angiology, 13, 508–510. [CrossRef]
  7. Pavan, R.; Jain, S.; Kumar, A. (2012). Properties and therapeutic application of bromelain: a review. Biotechnology research international, 2012. [CrossRef]
  8. Rathnavelu, V.; Alitheen, N.B.; Sohila, S.; Kanagesan, S.; Ramesh, R. (2016). Potential role of bromelain in clinical and therapeutic applications. Biomedical reports, 5, 283–288. [CrossRef]
  9. Yan, Y.; Tao, H.; He, J.; Huang, S.Y. (2020). The HDOCK server for integrated protein–protein docking. Nature protocols, 15, 1829–1852. [CrossRef]
  10. Yan, Y.; Zhang, D.; Zhou, P.; Li, B.; Huang, S.Y. (2017). HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy. Nucleic acids research, 45, W365–W373. [CrossRef]
Figure 1. shows the binding region, highlighting the interaction between Bromelain (as the receptor, represented in blue) and Apoptosis-associated speck-like containing CARD (as the ligand, depicted in red).
Figure 1. shows the binding region, highlighting the interaction between Bromelain (as the receptor, represented in blue) and Apoptosis-associated speck-like containing CARD (as the ligand, depicted in red).
Preprints 116911 g001
Table 1. Shows the docking results analysis, by HDOCK Server highlighting the interaction between Bromelain and Apoptosis-associated speck-like containing CARD.
Table 1. Shows the docking results analysis, by HDOCK Server highlighting the interaction between Bromelain and Apoptosis-associated speck-like containing CARD.
Receptor (PDB ID: 6U7D-PDB Chain A ID:2KN6Chain A) Docking Score (kcal/mol)
-208.89
Confidence Score
0.7646
Ligand rmsd(Å)
62.17
Table 2. Shows Receptor interface residue(s).
Table 2. Shows Receptor interface residue(s).
VAL    95A    2.149
ASP   96A   3.921
ALA   99A   2.707
ILE   104A   4.247
TRP   106A   3.988
ARG   107A   4.026
ASP   108A   2.023
TYR   109A   0.923
GLY   110A   2.807
ILE   136A   4.971
TYR   137A   1.729
LYS   138A   2.182
ILE   139A   1.108
LYS   140A   2.984
LYS   141A   4.059
GLY   142A   4.302
LEU   144A   4.118
ILE   174A   4.776
LYS   177A   3.584
ASN   201A   3.677
SER   202A   3.068
ALA   203A   3.243
TYR   204A   3.012
THR   206A   2.833
GLY   207A   3.447
TYR   208A   4.345
TYR   221A   0.946
SER   224A   3.491
LYS   225A   2.326
GLN   226A   3.104
TYR   310A   2.250
PRO   311A   3.689
THR   312A   2.204
LEU   313A   4.328
GLU   314A   2.966
SER   315A   2.853
Table 3. Shows Ligand interface residue(s).
Table 3. Shows Ligand interface residue(s).
MET 1A 2.149
GLY   2A   4.040
ARG   3A   0.946
ALA   4A   4.062
ARG   33A   2.182
GLU   34A   2.023
TYR   36A   2.728
TYR   60A   4.469
LEU   61A   0.923
GLU   62A   2.681
THR   63A   2.326
TYR   64A   3.020
GLU   67A   1.108
LEU   68A   5.000
ASN   71A   3.297
ARG   74A   4.048
ALA   82A   4.754
GLY   83A   3.277
GLN   86A   2.853
ALA   87A   4.392
THR   89A   3.396
HIS   90A   2.204
GLN   91A   2.966
GLY   92A   2.899
SER   93A   3.447
GLY   94A   2.833
ALA   95A   3.422
ALA   96A   4.451
GLY   99A   3.584
ILE   100A   3.054
GLN   101A   3.012
ALA   102A   3.909
PRO   103A   1.729
Table 4. Shows Receptor-ligand interface residue pair(s).
Table 4. Shows Receptor-ligand interface residue pair(s).
95A - 1A 2.149
95A - 2A   4.040
96A - 1A   4.397
96A - 2A   4.167
96A - 3A   3.921
99A - 1A   2.707
99A - 62A   3.792
104A - 61A   4.247
106A - 63A   4.365
106A - 64A   4.076
106A - 67A   3.988
107A - 34A   4.026
108A - 34A   2.023
108A - 36A   2.728
109A - 33A   4.188
109A - 34A   4.144
109A - 36A   3.403
109A - 60A   4.469
109A - 61A   0.923
109A - 64A   3.020
110A - 33A   2.807
110A - 34A   4.173
136A - 67A   4.971
137A - 103A   1.729
138A - 33A   2.182
138A - 64A   4.683
139A - 63A   4.681
139A - 67A   1.108
139A - 68A   5.000
139A - 71A   4.808
140A - 67A   3.532
140A - 71A   3.297
140A - 74A   4.048
140A - 86A   2.984
140A - 89A   3.396
140A - 90A   4.614
141A - 71A   4.518
141A - 74A   4.059
141A - 86A   4.584
142A - 33A   4.302
142A - 71A   4.416
144A - 33A   4.118
174A - 100A   4.776
177A - 99A   3.584
177A - 100A   3.687
201A - 103A   3.677
202A - 103A   3.068
203A - 103A   3.243
204A - 100A   3.054
204A - 101A   3.012
204A - 102A   3.909
204A - 103A   3.145
206A - 92A   4.127
206A - 93A   4.399
206A - 94A   2.833
206A - 95A  3.422
206A - 96A   4.451
207A - 93A   3.447
207A - 94A   4.592
207A - 95A   4.741
208A - 93A   4.345
221A - 3A   0.946
221A - 62A   4.666
224A - 63A   3.491
225A - 3A   2.779
225A - 4A   4.062
225A - 62A   2.681
225A - 63A   2.326
225A - 67A   4.109
225A - 89A   3.650
226A - 90A   3.104
310A - 90A   2.250
311A - 90A   3.689
312A - 90A   2.204
312A - 91A   4.804
312A - 92A   2.899
312A - 93A   4.147
313A - 86A   4.328
313A - 90A   4.368
313A - 92A   4.823
314A - 87A   4.392
314A - 90A   4.473
314A - 91A   2.966
314A - 92A   4.093
314A - 95A   4.088
315A - 74A   4.883
315A - 82A   4.754
315A - 83A   3.277
315A - 86A   2.853
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated